Herve Taillia

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score.

Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score.

Journal: Neurology
Published: December 19, 2017

New insights in radiation-induced leukoencephalopathy: a prospective cross-sectional study.

New insights in radiation-induced leukoencephalopathy: a prospective cross-sectional study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 25, 2017

Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit.

Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit.

Journal: Stroke
Published: September 25, 2017

Episodic Memory Impairments in Primary Brain Tumor Patients.

Episodic Memory Impairments in Primary Brain Tumor Patients.

Journal: Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
Published: March 15, 2017

Vascular cognitive impairment: Advances and trends.

Vascular cognitive impairment: Advances and trends.

Journal: Revue neurologique
Published: February 19, 2017

Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors.

Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors.

Journal: Investigational new drugs
Published: February 06, 2017

Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.

Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.

Journal: Cancer medicine
Published: October 13, 2015

Cognitive outcome after radiotherapy in brain tumor.

Cognitive outcome after radiotherapy in brain tumor.

Journal: Current opinion in oncology
Published: September 16, 2015

Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy.

Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy.

Journal: Journal of neuro-oncology
Published: April 13, 2015

Single center experience with bevacizumab in a cohort of patients treated for a relapsing glioblastoma

Single center experience with bevacizumab in a cohort of patients treated for a relapsing glioblastoma

Journal: Presse medicale (Paris, France : 1983)
Published: February 15, 2015

Supportive care, cognition and quality of life in brain metastases

Supportive care, cognition and quality of life in brain metastases

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: November 24, 2014

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 12, 2014
Showing 1-12 of 22

Last Updated: 09/26/2026